Cardinal Drug Limited - Company Profile

It is a pharma public limited company based in Gwalior, Madhya Pradesh, India, established in 1993.
1993 Gwalior, Madhya Pradesh, India Active
Last Updated:
Access Report
About Cardinal Drug Limited

Cardinal Drug Limited, a active public limited company, was established on 14 January 1993 in Gwalior, Madhya Pradesh, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24114MP1993PLC007463. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹6.60 Cr and a paid-up capital of ₹4.98 Cr.

Formerly known as Gwalior Fluorochem Limited, Gwalior Fluorochem Private Limited. It upholds a active non-compliant status. Its leadership includes Sunil Tarachand Kala (Director), Geetika Somani (Director), Anil Somani (Director). It holds ₹13.10 Cr open charges and ₹8.50 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at C/O Mercantile Agencies Jayendra Ganj, Gwalior, Madhya Pradesh, 474002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24114MP1993PLC007463

  • Registration Number

    007463

  • Incorporation Date

    14 January 1993

  • Authorized Capital

    ₹6.60 Cr

  • Paid-Up Capital

    ₹4.98 Cr

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 6.60 Cr
  • Paid Up Capital ₹ 4.98 Cr
  • Company Age 33 Year, 2 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 13.10 Cr
  • Satisfied Charges ₹ 8.50 Cr
  • Revenue Growth **** 175.30%
  • Profit Growth **** -878.48%
  • Ebitda **** -689.48%
  • Net Worth -2.54%
  • Total Assets **** 0.49%
Company report

Cardinal Drug Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Cardinal Drug Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Cardinal Drug Limited?
Current Directors
Name Designation Appointment Date Status
Sunil Tarachand Kala Director 01 Sep 1993 Current
Geetika Somani Director 14 Jan 1993 Current
Anil Somani Director 14 Jan 1993 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Cardinal Drug.

Cardinal Drug Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 175.3% increase. The company also saw a substantial fall in profitability, with a 878.48% decrease in profit. The company's net worth dipped by a decrease of 2.54%.

Cardinal Drug revenue growth over time
Cardinal Drug profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 175.30%
*******
*******
*******
*******
Revenue from Operations
*******
 175.93%
*******
*******
*******
*******
Total Assets
*******
 0.49%
*******
*******
*******
*******
Profit or Loss
*******
 -878.48%
*******
*******
*******
*******
Net Worth
*******
 -2.54%
*******
*******
*******
*******
EBITDA
*******
 -689.48%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Cardinal Drug?

In 2023, Cardinal Drug had a promoter holding of 87.60% and a public holding of 12.40%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹131,000,000.00

Satisfied Charges

₹85,000,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 12.20 Cr
  • M. P. Financial Corporation : 0.90 Cr
Latest Charge Details
Date Lender Amount Status
01 May 1997 State Bank Of India ₹7.60 Cr Open
29 Jan 1997 State Bank Of India ₹4.60 Cr Open
08 Jan 1997 M. P. Financial Corporation ₹9.00 M Open
29 Oct 1996 M. P. Financial Corporation ₹9.00 M Satisfied
26 May 1995 State Bank Of India ₹7.60 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Cardinal Drug?

Unlock and access historical data on people associated with Cardinal Drug, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Cardinal Drug, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cardinal Drug's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Cardinal Drug
Recent Activity within the Organization
  • Annual General Meeting

    The activity Cardinal Drug Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Cardinal Drug Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior. was completed.

  • Charges

    Progress on A charge registered on 26 May 1995 via Charge ID 90201624 with State Bank Of India was fully satisfied on 28 Jul 2006. was documented.

  • Charges

    A charge registered on 29 Oct 1996 via Charge ID 90210435 with M. P. Financial Corporation was fully satisfied on 26 May 2006. was recorded as a recent event.

  • Charges

    Progress on A charge with M. P. Financial Corporation of Rs. 0.90 Cr registered on 29 Oct 1996 with Charge ID 90210435 was modified on 11 Aug 1997. was documented.

  • Charges

    The activity A charge with State Bank Of India of Rs. 7.60 Cr registered on 26 May 1995 with Charge ID 90201624 was modified on 11 Aug 1997. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Cardinal Drug Limited?

The CIN of Cardinal Drug Limited is U24114MP1993PLC007463.

Where is Cardinal Drug Limited headquartered?

Cardinal Drug Limited is headquartered at C/O Mercantile Agencies Jayendra Ganj, Gwalior, Madhya Pradesh, 474002.

When was Cardinal Drug Limited incorporated?

Cardinal Drug Limited was incorporated on 14 January 1993.

Who are the current directors of Cardinal Drug Limited?

The current directors of Cardinal Drug Limited are

What is the primary industry of Cardinal Drug Limited?

The primary industry of Cardinal Drug Limited is Manufacturing.

Is Cardinal Drug Limited a listed company?

Cardinal Drug Limited is unlisted.

What is the capital structure of Cardinal Drug Limited?

The authorized capital of Cardinal Drug Limited is ₹6.60 Cr, and the paid-up capital is ₹4.98 Cr.

What is the compliance status of Cardinal Drug Limited?

The compliance status of Cardinal Drug Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available